Highmark Inc. has made its home in Pittsburgh since forming in 1996. Now, its sights are on Philadelphia in a big break with the past.
The Pittsburgh health system and insurance giant plans to start selling health insurance under the Highmark Blue Shield banner in the Philadelphia market in 2024 — a pivot that comes with both risk and opportunity.
Highmark, which now sells products in 62 of the state’s 67 counties, plans to enter the five-county Philadelphia market for the first time with a full court press of products, including self and fully insured, Medicare Advantage and Affordable Care Act plans.
The expansion will put it in direct competition with Independence Blue Cross, which was founded in 1938 and has dominated the five-county Philadelphia market for generations. It’s a big market, with some 4.2 million people or about one-third the state’s population, but here’s where things get tough: Independence is Pennsylvania’s biggest health insurer with 37% of the total market in 2020, according to a new report by the General Accounting Office.
Highmark is not shy about taking on the bigger company.
“It represents a gigantic opportunity for us,” Tom Fitzpatrick, senior vice president, commercial business, said Thursday. “We’re really excited about the opportunity in front of us.”
Independence Blue Cross responded with the statement, “We welcome healthy competition,” and a claim that it is well-positioned for the challenge.
“No one knows our region better or could serve it with more commitment,” spokesman Grant Gregwich wrote.
Highmark’s drive into Philadelphia marks a new era of health insurance competition in areas long controlled by one Blue plan. One estimate calculated that Independence Blue Cross has sewn up 90% of the Philadelphia health insurance market, a not-atypical scenario according to a class-action lawsuit brought by consumers in 2012 against the 34 Blue plans in the U.S.
Blue plan licensees are the biggest health insurers in 44 states, according to the lawsuit filed in the U.S. District Court for the Northern District of Alabama. Blue Cross Blue Shield of Alabama Group, for example, had 97% of the health insurance market in the state in 2020, according to the GAO report, which founded rising consolidation overall in the individual and small group markets in recent years.
Premera Blue Cross Group in Alaska, the second most concentrated market in the country after Alabama, controlled 91% of the health insurance market in 2020, the GAO found.
But a settlement reached in the lawsuit in August could bring lower premiums and more choices for consumers throughout the U.S., industry executives say, including in Pittsburgh where Blue plans — now free of geographical limitations — could enter with new, generic brand coverage that doesn’t come with the iconic Blue mark.
Blue Cross health insurance began in 1929 in a partnership between a local hospital and patients who were struggling financially to pay hospital bills. Blue Shield was created a year later as a way for patients to pay doctors and other medical providers.
Today, 24 million people are Blue Cross members.
Before the lawsuit, the Blue Cross Blue Shield Association had limited the sale of Blue branded products to licensees in specific areas of the country, but now Blue plans can enter new markets with unbranded policies, something the association had tightly restricted in the past.
Blue-on-Blue
Highmark isn’t a newbie when it comes to Blue-on-Blue competition; 20 years ago, the insurer entered the 17 counties of central Pennsylvania to compete against Harrisburg-based Capital Blue Cross and now has 1.1 million members in the region.
And Highmark is no stranger to Independence Blue Cross. Highmark and Independence had sought to merge in 2007. They called off the deal two years later when the state Insurance Department required Highmark to relinquish either its Blue Cross or Blue Shield brand as a condition of state approval.
The big change came in August with a $2.67 billion antitrust settlement involving Highmark and 33 other Blue licensees, which reshaped the health insurance landscape in the U.S. and set the stage for Highmark’s move to the southeast part of the state.
The settlement, which ended litigation brought by a retired chiropractor and other consumers, prohibited longstanding Blue plan restrictions that allegedly limited competition and drove up consumer health insurance costs.
In granting preliminary approval to the settlement, U.S. District Judge R. David Proctor in Birmingham, Ala. wrote that the deal’s “structural relief is historic and substantial.”
Highmark’s share of the settlement payment was $132 million. A related lawsuit brought by hospitals and doctors is still pending against the Blue plans.
The Blue Cross Blue Shield Association, a Chicago-based trade group, awards specific territorial rights to Blue licensees and has historically discouraged member plans from competing for the same business. Soon though, Philadelphia-area consumers and businesses will be free to request a bid from a second Blue insurer, fostering the kind of Blue-on-Blue competition the class-action settlement sought as relief.
But Highmark may not have an easy time breaking into the market.
“I’m not saying it’s impossible, but it’s going to be a tough road to get in,” said Mike Garvey, founder of Pro Health Plans in Media, Pa. and an insurance broker for 30 years. “They’ll be inching their way in rather than diving in. People don’t know Highmark from the other side of the state. They just don’t.”
‘Frenemies’
Highmark, the fourth largest Blue licensee in the U.S., reported consolidated revenue of $22 billion for 2021, compared to $24.7 billion for Independence Blue Cross.
The sheer size of the Philadelphia market represents a big opportunity for growth in what will be among president and CEO David Holmberg’s boldest moves since assuming leadership of the company in 2014. Since then, he was increased Highmark revenue by 31% from $16.8 billion while reaching a truce with rival UPMC in 2019 that allows Highmark members to see UPMC doctors.
The push into Philadelphia won’t end the insurer’s cooperation with Independence Blue Cross. For example, Highmark will continue partnering with Independence and other Blue plans in startups Synergie Medication Collective and Evio Pharmacy Solutions, both of which are focused on medication effectiveness and affordability.
But there will be other areas where the two companies will be rivals, Mr. Fitzpatrick at Highmark said.
“To the extent that we can continue to collaborate, we’re going to continue to do that,” he said. “But in certain instances, ‘frenemies’ probably applies.”
Kris B. Mamula: kmamula@post-gazette.com





Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.